
Medpace Investor Relations Material
Latest events

Q3 2024
Medpace
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Medpace Holdings Inc
Access all reports
Medpace Holdings Inc., a full-service clinical research organization, provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers therapeutic expertise in the areas of endocrinology, gastroenterology, general medicine, hematology/oncology, infectious diseases/vaccines, and neuroscience.
Key slides for Medpace Holdings Inc


Q3 2024
Medpace Holdings Inc


Q3 2024
Medpace Holdings Inc
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
MEDP
Country
🇺🇸 United States